Recombinant TNFRSF17 (Ispectamab Biosimilar) antibody
This Humanized Chimeric antibody specifically detects TNFRSF17 (Ispectamab Biosimilar) . It exhibits reactivity toward Human.
Catalog No. ABIN7597758
$357.68
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant TNFRSF17 (Ispectamab Biosimilar) antibody (ABIN7597758)
Target
TNFRSF17 (Ispectamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This TNFRSF17 (Ispectamab Biosimilar) antibody is un-conjugated
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Ispectamab Biosimilar Antibody
-
Specificity
- Tumor necrosis factor receptor superfamily member 17, TNFRSF17, CD269, B-cell maturation protein, BCMA, BCM
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- TNFRSF17 (Ispectamab Biosimilar)
-
Alternative Name
- Ispectamab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Tumor necrosis factor receptor superfamily member 17, TNFRSF17, CD269, B-cell maturation protein, BCMA, BCM
-
UniProt
- Q02223
-
CAS-No
- 2413386-21-5
Target
-
You are here:
